ADMA 241220 9.00P (ADMA241220P9000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

ADMA241220P9000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 2 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating
Moomoo News35minutes ago · Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga12:35 ET
ADMA Biologics (NASDAQ:ADMA) Seems To Use Debt Quite Sensibly
Simply Wall StNov 28 10:00 ET
Adma Biologics (ADMA) Is on the Move, Here's Why the Trend Could Be Sustainable
Zacks Nov 27 08:00 ET
Insider Sale: CFO and Treasurer of $ADMA (ADMA) Sells 15,000 Shares
Quiver QuantitativeNov 22 21:16 ET
ADMA Biologics Announces Board Resignations and Appointments
TipRanksNov 21 16:57 ET

Comments

sharphooks

16 hours ago

$ADMA Biologics (ADMA.US)$ strange drop. Any negative news?

sharphooks

Nov 20 16:28

$ADMA Biologics (ADMA.US)$ woohoo

Krezash

Nov 8 04:03

$ADMA Biologics (ADMA.US)$ as expected, they smashed their earnings again 💵🔥

Krezash

Nov 1 05:05

Here we goooo

$ADMA Biologics (ADMA.US)$ getting one of the Big 4 to audit them and having their earnings in 7 days, this is going to shoot up in the next week 🚀

Krezash

Oct 31 20:23

$ADMA Biologics (ADMA.US)$ ADMA Biologics, Inc. (NASDAQ:ADMA), a biopharmaceutical company, announced on Thursday that it has appointed KPMG LLP as its new independent registered public accounting firm. The engagement with KPMG is effective immediately following the filing of ADMA's Quarterly Report for the fiscal quarter ended September 30, 2024.